Enliven Therapeutics (ELVN) Earnings Date, Estimates & Call Transcripts $29.28 -0.27 (-0.91%) (As of 02:07 PM ET) Add Compare Share Share Earnings Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends Enliven Therapeutics Latest Earnings SummaryUpcoming Earnings DateNov. 14EstimatedActual EPS (Aug. 13) -$0.41 Beat By $0.17 Consensus EPS (Aug. 13) -$0.58 Enliven Therapeutics released Q2 2024 earnings on August 13, 2024, reporting an EPS of -$0.41, which topped analysts' consensus estimates of -$0.58 by $0.17. With a trailing EPS of -$1.93, Enliven Therapeutics' earnings are expected to decrease next year, from ($1.98) to ($2.37) per share. ELVN Upcoming EarningsEnliven Therapeutics' next earnings date is estimated for Thursday, November 14, 2024, based off prior year's reporting schedules. Get Enliven Therapeutics Earnings Alerts Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Enliven Therapeutics and other key companies, straight to your inbox. Enter your email to sign up for newsletter Sign Up Skip Charts & View Estimated and Actual Earnings DataELVN Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.ELVN Estimated and Actual Revenue by QuarterEstimated Revenue and Actual Revenue by Quarter Chart DescriptionThe chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter. Ad Porter & CompanyThe Final FrontierAnd a lot of powerful investors would rather this exposé never saw the light of day. I suspect they’ll attempt to discredit it, tar and feather it, and convince you not to watch it. That’s because it tells the shocking truth about the current AI mania… and why investors in big tech companies like Nvidia, Meta, Alphabet, and Microsoft could be in for a whole world of pain.Here’s the full story for you. Enliven Therapeutics Analyst EPS EstimatesQuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateQ2 20241-$0.51-$0.51-$0.51Q3 20242-$0.55-$0.46-$0.51Q4 20242-$0.57-$0.49-$0.5320245-$1.63-$1.46-$1.55Q1 20251-$0.52-$0.52-$0.52Q2 20251-$0.55-$0.55-$0.55Q3 20251-$0.58-$0.58-$0.58Q4 20251-$0.60-$0.60-$0.60FY 20254($2.25)($2.25)($2.25) Enliven Therapeutics Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years 10 Years Time Frame * Start Date * End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueLinks 11/14/2024(Estimated)------- 8/13/2024--$0.58-$0.41+$0.17-$0.41--5/14/2024Q1 2024-$0.58-$0.54+$0.04-$0.54-- 3/14/2024Q4 2023-$0.56-$0.47+$0.09-$0.47--11/9/2023Q3 2023-$0.49-$0.51 -$0.02-$0.51-- 8/10/2023Q2 2023-$0.40-$0.41 -$0.01-$0.41-- 5/11/2023Q1 2023-$0.67-$0.80 -$0.13-$0.80-- Get the Latest News and Ratings for ELVN and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Enliven Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 2/10/2023Q4 2022-$4.92+$4.92$4.92-- Enliven Therapeutics Earnings - Frequently Asked Questions When is Enliven Therapeutics's earnings date? Enliven Therapeutics has not confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, November 14th, 2024 based off last year's report dates. Learn more on ELVN's earnings history. Did Enliven Therapeutics beat their earnings estimates last quarter? In the previous quarter, Enliven Therapeutics (NASDAQ:ELVN) reported ($0.41) earnings per share (EPS) to beat the analysts' consensus estimate of ($0.58) by $0.17. Learn more on analysts' earnings estimate vs. ELVN's actual earnings. How much profit does Enliven Therapeutics generate each year? Enliven Therapeutics (NASDAQ:ELVN) has a recorded net income of -$71.58 million. ELVN has generated -$1.93 earnings per share over the last four quarters. What is Enliven Therapeutics's EPS forecast for next year? Enliven Therapeutics's earnings are expected to decrease from ($1.98) per share to ($2.37) per share in the next year. ` More Earnings Resources from MarketBeat Related Companies AVDL Earnings Date NTLA Earnings Date DCTH Earnings Date EDIT Earnings Date FULC Earnings Date BLUE Earnings Date CRSP Earnings Date CORT Earnings Date BBIO Earnings Date BHVN Earnings Date Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Latest Articles Roblox Stock Soars 22% After Q3 Earnings – A Turning Point Ahead?Apple Earnings - When Really Good Just Isn’t Good Enough Roblox Stock Set for More Gains After Strong Earnings ReportAmazon: Why Analysts Think It's a Solid Buy Ahead of EarningsLam Research Proves Analysts Wrong with a Strong Earnings ReportPulteGroup Earnings Signal Potential Entry Points for InvestorsTaiwan Semiconductor Soars on Earnings With More Room to Run The Final Frontier (Ad)And a lot of powerful investors would rather this exposé never saw the light of day. I suspect they’ll attempt to discredit it, tar and feather it, and convince you not to watch it. That’s because it tells the shocking truth about the current AI mania… and why investors in big tech companies like Nvidia, Meta, Alphabet, and Microsoft could be in for a whole world of pain.Here’s the full story for you. This page (NASDAQ:ELVN) was last updated on 11/7/2024 by MarketBeat.com Staff From Our PartnersBill Gates’s Next Big AI Bet: StargateIn February 2016… when almost nobody was talking about artificial intelligence…. I picked Nvidia as one of ...Brownstone Research | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredEx WH Advisor Who Predicted Biden Leaving Race Makes Startling New PredictionFormer advisor to the CIA, the Pentagon and the White House Jim Rickards went on multiple TV news programs… ...Paradigm Press | Sponsored626 winning trades out of 647…Imagine turning nearly every Friday into a payday. That's exactly what one reclusive multi-millionaire trad...Investing Daily | SponsoredCrypto Crash Ahead? (27 Experts Weigh In)Your Portfolio Could Be at RISK Emergency summit reveals crypto could save you!Crypto 101 Media | SponsoredHow high could Bitcoin go?Donald Trump wants to be America’s first crypto president. He was the keynote speaker at the recent Bitcoin co...Weiss Ratings | SponsoredThe Final FrontierAnd a lot of powerful investors would rather this exposé never saw the light of day. I suspect they’ll attempt...Porter & Company | Sponsored24/7 Automated Profits in CryptoThe 4th quarter of 2024 is shaping up to be one of the most explosive periods for crypto in recent memory. But...Crypto Swap Profits | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Enliven Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Enliven Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free ELVN Stock Alerts